Project CASCADE: Community and Academic Synergy for Cancer Survivorship Care Delivery Enhancement

Part of paid clinical trials in Houston, Texas.

Sponsor
The University of Texas Health Science Center, Houston
Study ID
NCT06883838
Status
Enrolling By Invitation

Conditions

  • Cancer Survivorship

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Survivorship care delivery intervention — BEHAVIORAL
    Guided by the Practical, Robust Implementation and Sustainability Model (PRISM), the intervention includes three evidence-based components: 1. Training: This will include provider-to-provider tele-mentoring using Enhancing Community Health Outcomes (ECHO). 2. Tracking: This includes systematically assessing cancer history and monitoring survivors' care to plan and organize subsequent care. 3. Coordinating care for cancer survivors. Each clinic leader will designate a staff member (or members) as the care coordinator champion after exploring current clinic staff, skills, and capacity of various staff roles.

Study Details

The purpose of this study is to implement a clinic-level cancer survivorship care delivery intervention in partnership with community health center clinicians, patients, and community representatives to test effectiveness of the intervention to improve patient and clinician outcomes and to evaluate implementation of the intervention using an iterative, concurrent mixed-methods approach guided by the Practice Change Model.

Key Dates

Start date
Sep 1, 2025
Status verified
Oct 2025
Primary completion
May 31, 2029
Completion
May 31, 2029

Study Design

Enrollment
5,584 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: Step 1 (2 clinics)-6 months control then 12 months intervention
  • Experimental: Step 2 (2 clinics)-12 months control then 12 months intervention
  • Experimental: Step 3 (2 clinics)-18 months control then 12 months intervention
  • Experimental: Step 4 (2 clinics)- 24 months control then 12 months intervention

Primary Outcome Measure

Proportion of eligible cancer survivors screened for second primary cancers [ Time Frame: every 6 months from baseline to end of study (about 36 months from baseline) ]

Locations (1)

FacilityCityStateZIPSite coordinators
The University of Texas Health Science Center, HoustonHoustonTexas77030-

Find similar trials in Houston, TX

By research site
The University of Texas Health Science Center, Houston· Houston, TX

Related Studies